Hopital FOCH
Suresnes, Île-de-France Region, 92151, France
NCT Number: NCT04213781
Oocyte retrieval procedure for in vitro fertilization is a source of anxiety for patients. Local anaesthesia or sedation are commonly used to manage many situations of anxiety, including the oocyte retrieval. However, this sedation should be as mild as possible in order to preserve oocytes.
HappyMed Video Glasses are a recent medical device that allows the immersion of patients in films, cartoons or concerts. By distracting patients, this technology can reduce anxiety, discomfort and ultimately pain associated with care.
This randomized monocentric trial compares audiovisual distraction versus usual care for the management of anxiety and pain related to oocyte retrieval.
Hypothesis of this study is that the audiovisual distraction carried out with the HappyMed Video Glasses reduces the use of sedative drugs during oocyte retrieval while ensuring a better comfort and a faster walking ability.
Looking for future studies?
Notify Me18 year–43 year
Female
Interventional
Not applicable
Suresnes, Île-de-France Region, 92151, France
Consent female patients between 18 and 43 years old scheduled for oocyte retrieval will be enrolled in this study and their anxiety level will be collected via a questionnaire.
After randomization, patients will either benefit from audiovisual distraction using HappyMed Video Glasses, (medical device with CE marking), or from the usual management during procedure. The anaesthesiologist will check that no anxiolytic or sedative drug was given 12 hours before anaesthesia. The patients will be stratified according to whether or not a previous intervention was performed. Anaesthesia will be started and maintained with administration of sufentanil (0.1 μg/kg) and propofol (using the Dixon's up-and-down method). The aim is a patient who spontaneously ventilates and does not react to gynaecological stimulation. Prevention of postoperative pain and nausea/vomiting will be carried out at the initiation of the surgical procedure. The effect of these drugs is longer than the intervention duration and will not influence the protocol.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
HappyMed allows the immersion of patients in films, cartoons or concerts.
The dosage is modified according to the Dixon's up-and-down method (using 0.5 µg/ml as a step size). The first patient in each group will start at a dose 3 µg/ml propofol. If patient manifests discomfort then the next patient will receive an increment of 0.5 µg/ml propofol, if patient is comfortable, then the next patient received a decrement of 0.5 µg/ml propofol.
0.1 µg/kg
Time frame: Intraoperative period : from the start of anaesthesia to the end of the intervention
An up and down method will define the CP 50 in each group.
Time frame: 4 hours
Onset of vertigo, nausea or headaches
Time frame: 30 minutes
Comfort behavior scale : it incorporates three categories of behavior : Facial expression (0=relaxed ; 1= frowning ; 2=grimacing) ; Verbal response (0=none ; 1= moans ; 2=verbal protest) ; Arm movement (0=none ; 1=medium ; 2=strong). Each scored on a 0-2-point scale so that the total score ranges from 0 to 6.
Time frame: up to 24 hours (from the start of anaesthesia to the patient's discharge of the recovery room)
Occurence of desaturation event (SpO2< 92%), respiratory distress event (RR<10 breaths per minute) or bronchospasm.
Time frame: 12 hours
Duration between the end of the procedure and the standing position.
Time frame: 2 hours
Satisfaction VRS ranging from 0 to 4 (0=unsatisfied, 4=very satisfied).
Time frame: 4 hours
Satisfaction VRS ranging from 0 to 4 (0=unsatisfied, 4=very satisfied).
Time frame: 24 hours
Numeric scale from 0 to 10 (0=bedridden, 10=resuming total activities).
CMC Ambroise Paré
Other
Does Audiovisual Distraction Decrease the Use of Hypnotic Drugs During Oocyte Retrieval?
Acronym: Happy-Fiv
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04935658
Agnosia, Behavior
Clermont-Ferrand, France
View Trial DetailsNCT01304511
Fertilization in Vitro
View Trial DetailsNCT05225155
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Santo André, São Paulo, Brazil
View Trial DetailsNCT05244538
Conscious Sedation, Fertilization in Vitro
Brussels, Belgium
View Trial Details